LSIC Lifeline Sci

TIDMLSIC

RNS Number : 1393C

Lifeline Scientific, Inc

23 June 2016

Lifeline Scientific, Inc.

("Lifeline" or the "Company")

Result of AGM

Lifeline Scientific (AIM: LSIC), the transplantation technology company, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

For further information:

 
 Lifeline Scientific, Inc.                              www.lifeline-scientific.com 
 David Kravitz, CEO                                            Tel: +1 847 294 0300 
 Lisa Kieres, CFO                                              Tel: +1 847 294 0300 
 
 Panmure Gordon (UK) Limited                               Tel: +44 (0)20 7886 2500 
 Freddy Crossley (Corporate 
  Finance) 
 Tom Salvesen (Corporate 
  Broking) 
 
 Walbrook PR Limited           Tel: +44 (0) 20 7933 8780 or lifeline@walbrookpr.com 
 Lianne Cawthorne                                          Mob: +44 (0)7584 391 303 
 Mike Wort                                                 Mob: +44 (0)7900 608 002 
 

About Lifeline Scientific Inc.

Lifeline Scientific, Inc. is a Chicago-based global medical technology company with regional offices in Brussels and Sao Paulo. The Company's focus is the development of innovative products that improve transplant outcomes and lower the overall costs of transplantation. Its lead product, LifePort Kidney Transporter, is the global market-leading medical device for hypothermic machine preservation of donor kidneys. LifePorts and novel solutions designed for preservation of other organs are in development, with LifePort Liver Transporter next in line for commercial launch. For more information please visit www.lifeline-scientific.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGAKNDDABKDCAB

(END) Dow Jones Newswires

June 23, 2016 12:21 ET (16:21 GMT)

Lifeline Sci (LSE:LSIC)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Lifeline Sci (LSE:LSIC)
Gráfica de Acción Histórica
De May 2023 a May 2024